{"brief_title": "Insulin, Neurogenetics and Memory in Alzheimer's Disease", "brief_summary": "This study examines the use of insulin-sensitizing compounds, as therapeutic agents for cognitive impairment in Alzheimer's disease.", "condition": "Alzheimer Disease", "intervention_type": "Drug", "intervention_name": "rosiglitazone", "criteria": "Men and women with mild Alzheimer's Disease without serious medical or psychiatric comorbid conditions.", "gender": "All", "minimum_age": "55 Years", "maximum_age": "80 Years", "healthy_volunteers": "No", "id": "NCT00018382.xml"}